Medical Device Contract Manufacturing Market Size, Share, and Industry Analysis By Product Type (Class I Medical Devices, Class II Medical Devices, and Class III Medical Devices), By Service Type (Accessories Manufacturing, Device Manufacturing, Packaging and Labeling, and Others), By Device Type (Cardiovascular Devices, Orthopedic Devices, Drug Delivery Devices, Diagnostic Imaging Devices, Respiratory Devices, and Others), By End User (Original Equipment Manufacturers (OEMs), Pharmaceutical & Biopharmaceutical Companies, and Others), and Regional Forecast, 2026-2034

The global medical device contract manufacturing market size was valued at USD 87.43 billion in 2025. The market is projected to grow from USD 98.38 billion in 2026 to USD 252.95 billion by 2034, exhibiting a CAGR of 12.53% during the forecast period.

The global medical device contract manufacturing market is developing owing to regulatory initiatives, the adoption of advanced manufacturing processes, and outsourcing trends. MDCM means outsourcing the manufacturing of medical devices to specialized companies that guarantee the cost-efficient production of medical devices with compliance to regulations and quality control on behalf of OEMs and healthcare companies.

• According to FDA, the U.S. FDA regulates over 6,500 medical device companies.

Medical Device Contract Manufacturing Market Driver

Regulatory Initiatives Promoting Quality Manufacturing, Adoption of Advanced Manufacturing Technologies to Foster the Demand for Medical Device Contract Manufacturing

The Case for Quality (CfQ) initiative by the FDA propounds that medical device manufacturers apply advanced manufacturing practices to foster enhanced product quality and augmented patient safety, as well as regulatory adherence, thereby promoting growth and innovation within the Medical Device Contract Manufacturing market.

The FDA attempts to promote precision drug design, automated processes, and advanced manufacturing technologies, said advantages to production processes and the quality of the produced drug, thereby making contract manufacturers embrace these tools in large numbers, ensuring precision, scalability, and regulatory compliance in the manufacturing of medical devices, thereby stimulating growth in the MDCM market.

Medical Device Contract Manufacturing Market Restraint

Regulatory Compliance Complexities, Supply Chain Vulnerabilities May Affect Market Expansion

Given the global strict regulations, including the FDA QSR and other regulatory standards, compliance constitutes a great challenge to contract manufacturers, which in turn increases the cost of doing business and prolongs the time for product approval.

Over-reliance on sterilization methods such as ethylene oxide (EtO) presents the MDCM market with disruptions from changes in regulations and safety concerns, subsequently affecting all timelines in production, supply chain reliability, and overall efficiency in manufacturing.

Medical Device Contract Manufacturing Market Opportunity

Implementation of Smart Manufacturing Practices, Regulatory Support for Advanced Manufacturing to Offer New Growth Avenues

The Smart Design and Manufacturing Pilot initiated by the FDA advancements in software and digital design for both automation and contract manufacturers, taking the MDCM market further due to the increased efficiency, ensuring precision, and maximizing product quality.

Efforts such as the FDA-Siemens Government Technologies partnership promote the uptake of advanced manufacturing technologies, allowing contract manufacturers to develop along increased regulatory alignment, new product introductions, and optimized production operations.

Segmentation

Key Insights

The report covers the following key insights:

• Regulatory Initiatives and Compliance Challenges Across Key Regions
• Adoption of Advanced Manufacturing Technologies and Automation Trends
• Key Market Drivers, Growth Trends, and Emerging Investment Opportunities
• Strategic Business Moves by Leading Players (Mergers, Acquisitions, Partnerships)
• Overview: Evolving Regulatory Frameworks and Government Support Policies

Analysis by Product Type

By product type, the medical device contract manufacturing market is divided into Class I Medical Devices, Class II Medical Devices, and Class III Medical Devices.

The Class I category of medical devices has been significantly growing on ever-increasing demand for low-hazard, low-cost medical products, and thus significantly increasing outsourcing to contract manufacturers for producing an efficient product and regulatory compliance.

The Class II medical devices segment is mostly experiencing a huge spurt in demand as a result of introducing regulation and even advances in the technology, which have created strong dependencies of medical companies on contract manufacturers to precision machine and manufacture products with scalable quantities. The use of moderate-risk therapeutic and diagnostic devices in the Class II Medical Devices segment will place the focus of the market.

Analysis by Service Type

Based on service type, the medical device contract manufacturing market is subdivided into accessories manufacturing, device manufacturing, packaging and labeling, and others.

The Accessories Manufacturing segment is significantly expanding as, due to the increasing demand for high-quality components, medical device companies are likely to look towards contract manufacturing for efficient production, regulatory compliance, and product reliability.

The device manufacturing section is increasing as increasingly medical devices are shifting from traditional manufacturing techniques to it. Largely, these medical companies are looking for specialized knowledge and scalable production from contract manufacturers in advanced technologies, streamlined processes, and stricter quality control with regard to market requirements. Device manufacturing stands tall as the most dominating segment because of increased outsourcing by OEMs in complex medical device manufacturing processes.

Analysis by Device Type

By device type, the medical device contract manufacturing market is fragmented into cardiovascular devices, orthopedic devices, drug delivery devices, diagnostic imaging devices, respiratory devices, and others.

The market for cardiovascular devices is buoyant due to the progressing morbidity of heart diseases, which has attracted the attention of medical companies towards outsourcing manufacturing solutions for high-precision devices using advanced technologies as well as regulatory compliance. The ever-increasing rate of cardiovascular diseases and the accompanying technological advancements run the gamut under the cardiovascular devices continuum of advanced technology to regulatory compliance.

The orthopedic segment is experiencing expanded demand for implants and prosthetics for stable contract manufacturers who have generated agreements with medical companies for resource-efficient, innovative, and high-quality manufacturing.

Analysis by End User

Based on end user, the medical device contract manufacturing market is divided into Original Equipment Manufacturers (OEMs), pharmaceutical & biopharmaceutical companies, and others.

The OEM sector has continued to increase and is currently being supplemented by a further increase in the dependence on contract manufacturers for low-cost production, regulatory compliance, and integration of advanced technologies for faster product development and market access. Further, the Original Equipment Manufacturers (OEM) segment dominates owing to a high level of outsourcing in the manufacturing of medical devices for cost reduction and scalability.

The pharmaceuticals and biopharmaceutical companies are growing in this segment due to increased outsourcing activities of such specialized manufacturers for compliance with high-quality standards, scalability, and evolving regulations in the medical device industry.

Regional Analysis

To gain extensive insights into the market, Download for Customization

Based on region, the medical device contract manufacturing market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

The North America medical device contract manufacturing market is the major section, as far as FDA schemes such as the Case for Quality and Smart Manufacturing Programs, which are to advance manufacturing practices for assurance in compliance, efficiency, and innovation in the medical device manufacturing business.

The European medical device contract manufacturing market thrives on the relationship between regulatory agencies and industry players, whereby harmonization of standards and the approval process is enabled, thereby further improving the manufacturing efficiency that connects all the way from legislation on the high-quality medical device production enforcement all over the region.

The medical device contract manufacturing market in the Asia Pacific is likely to grow at a high rate as healthcare investments increase and manufacturing capabilities expand so that local companies will adopt modern machinery and methods to meet extremely high demand for cost-withstanding, good-quality medical devices.

Key Players Covered

The report includes the profiles of the following key players:

• Jabil Inc. (U.S.) 
• Thermo Fisher Scientific Inc. (U.S.) 
• Integer Holdings Corporation (U.S.) 
• Flex Medical Solutions Ltd (U.K.) 
• Sanmina Corporation (U.S.) 
• Phillips-Medisize (U.S.) 
• Plexus Corp. (U.S.) 
• Viant (U.S.) 
• West Pharmaceutical Services, Inc. (U.S.) 
• Mack (U.S.) 
• Cirtec (U.S.) 
• Coghlin Companies, Inc. (U.S.) 

Key Industry Developments

• Concluded in December 2024, Medical Device Sterilization Town Hall Series addressed challenges and advancements in sterilization methods, including discussions on reducing reliance on ethylene oxide, impacting contract manufacturing practices. 
• In May 2023, the FDA updated its Catalog of Regulatory Science Tools to include new resources for additively manufactured medical devices, facilitating industry adoption of advanced manufacturing technologies. 
• Initiated in June 2021 and concluded in October 2024, FDA's Smart Design and Manufacturing Pilot aimed to implement advanced industrial software for digital design and automated manufacturing, supporting the broader adoption of smart manufacturing processes in FDA-regulated products.